Executive Vice President, Research & Development
United States of America
Joseph Monahan, Ph.D., joined Aclaris Therapeutics as Executive Vice President, Research & Development, with more than 30 years of pharmaceutical experience. Prior to joining Aclaris, he founded the biotechnology company Confluence Life Sciences, Inc. in 2010. He has also held multiple research leadership positions at Pfizer Inc. including Executive Director, Inflammation Research; Global Kinase Platform Leadership Team; Site Head of Enzymology and Biophysics; and Inflammation Research Clinical Development Lead. Throughout his career, Dr. Monahan led the advancement of project portfolios from early discovery through Phase 1 and 2 clinical development. He has held adjunct and visiting professor positions at Washington University Medical School and University of California, Los Angeles School of Medicine. He has published over 80 peer-reviewed publications and is co-inventor on 12 patents. Dr. Monahan received his Bachelor of Science in Biochemistry from the University of New York at Buffalo and Doctor of Philosophy in Biochemistry from the University of South Carolina.
Host defense mechanisms,LPS effects on neurotransmitters